Bacteria discovery leads to novel probiotic for eczema

Low-Res_roseomonas-mucosa

Source: NIAID

Research has led to the availability of a new over-the-counter topical eczema probiotic, based on the discovery that bacteria present on healthy skin called Roseomonas mucosa can safely relieve eczema symptoms in adults and children.

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE